{"entity":{"id":"nct05050942","kind":"trial","name":"A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET","aka":["SORENTO"],"tldr":"A phase 3 trial of CAM2029 (octreotide subcutaneous depot) run by Camurus AB, active.","summary":"A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET is a phase 3 interventional study registered as NCT05050942 by Camurus AB, with 332 participants enrolled, started 2021-10-22. Conditions listed: Gastro-enteropancreatic Neuroendocrine Tumor. No results are recorded here; the registry entry is the source.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT05050942","url":"https://clinicaltrials.gov/study/NCT05050942"}],"tags":["ctgov-ingest"],"related":[],"cancers":["neuroendocrine","pancreatic-net","small-intestinal-net"],"sections":[],"technologies":["endocrine-therapy"],"targets":[],"drugs":["cam2029"],"companies":["camurus"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05050942","phase":"3","setting":"A Randomized, Multi-center, Open-label, Active-controlled Phase 3 Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) Versus Octreotide LAR or Lanreotide ATG in Patients With GEP-NET","sponsor":"Camurus AB","started":"2021-10-22","startedType":"actual","enrolled":332,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05050942/","neighbours":{"cancer":[{"id":"neuroendocrine","kind":"cancer","name":"Neuroendocrine tumours","route":"/cancers/neuroendocrine/"},{"id":"pancreatic-net","kind":"cancer","name":"Pancreatic neuroendocrine tumours","route":"/cancers/pancreatic-net/"},{"id":"small-intestinal-net","kind":"cancer","name":"Small intestinal neuroendocrine tumours","route":"/cancers/small-intestinal-net/"}],"technology":[{"id":"endocrine-therapy","kind":"technology","name":"Endocrine therapy (SERMs, AIs, SERDs)","route":"/technologies/endocrine-therapy/"}],"drug":[{"id":"cam2029","kind":"drug","name":"CAM2029 (octreotide subcutaneous depot)","route":"/drugs/cam2029/"}],"company":[{"id":"camurus","kind":"company","name":"Camurus","route":"/companies/camurus/"}]}}